Jefferies rates Diageo a 'buy' amid Ciroc sale rumours
Jefferies has reiterated a 'buy' rating for on the back of speculation that the drinks giant is considering a sale of its Ciroc brand, saying that any potential sale would be accretive to top-line growth.
A Bloomberg report on Thursday said that Diageo has approached potential bidders to gauge interest regarding the sale of its vodka brand, Ciroc.
The speculation follows a breakdown in the relationship with once-brand ambassador and co-owner Sean 'Diddy' Combs, who is current facing allegations of racketeering and sex trafficking.
Jefferies cited IWSR data which suggests that Ciroc amounted to 1.4m cases and $1.47bn in retail sales in 2023, which the broker said equates to 0.5% of Diageo's group volumes and 2-3% of sales.
"We have detected a decreasing emphasis placed on the brand, which saw an organic sales decline of -26% in F24. We estimate that the disposal could be accretive >50bps to group growth," the broker said.
Regarding the wider group's business, Jefferies said 2025 will be a "trough year" for Diageo, with a recovery expected thereafter.
"Companies do not change overnight; however, we think that Diageo will start to look different as confidence in spirits growth increases and under a new, heavyweight CFO, where we expect to see a renewed focus on growth, profit and cash," the broker said.
Jefferies kept a 2,800p target price for the stock, which was down 1% at 2,501p by 1026 GMT.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.